Evidence map›Paper›PMID 33445850›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Clinical characteristics and prognosis of Waldenström's macroglobulinemia: a clinical data report from a single center].

Y C Jia, J Lu, W T Qiang, L Li, J Liu, H Jiang, W J Fu, J Du

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Y C JiaDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
J LuDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
W T QiangDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
L LiDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
J LiuDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
H JiangDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
W J FuDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
J DuDepartment of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
Shanghai Changzheng Hospital · CN

Funding

National Natural Science Foundation of China 81870164, 81372543
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Waldenstrom MacroglobulinemiaAgedFemaleHumansMaleMyeloid Differentiation Factor 88PrognosisPyrimidinesRetrospective StudiesMyeloid Differentiation Factor 88PyrimidinesClinical characteristicsGene, MYD88IbrutinibResponse timeWaldenström's macroglobulinemia

Identifiers

PMID33445850
PMCPMC7840552
OpenAlexW3122153975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.